Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes of Transrenal Artery Perfusion Versus Transrenal Vein Perfusion Using LifePort for Deceased Donor Kidney Transplantation

NCT04569682 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT04569682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04569682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes of Transrenal Artery Perfusion Versus Transrenal Vein Perfusion Using LifePort for Deceased Donor Kidney Transplantation
Lead sponsor
West China Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2020
Completion date
December 30, 2022
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation, organ preservation